title: Selective gene expression in brain microglia mediated via adeno-associated virus type 2 and type 5 vectors.
abstract: Microglia represent a crucial cell population in the central nervous system, participating in the regulation and surveillance of physiological processes as well as playing key roles in the etiologies of several major brain disorders. The ability to target gene transfer vehicles selectively to microglia would provide a powerful new approach to investigations of mechanisms regulating brain pathologies, as well as enable the development of novel therapeutic strategies. In this study, we evaluate the feasibility of specifically and efficiently targeting microglia relative to other brain cells, using vectors based on two different serotypes of adeno-associated virus (AAV) carrying cell-type-specific transcriptional elements to regulate gene expression. Among a set of promoter choices examined, an element derived from the gene for the murine macrophage marker F4/80 was the most discriminating for microglia. Gene expression from vectors controlled by this element was highly selective for microglia, both in vitro and in vivo. To our knowledge, this is the first demonstration of selective expression of transferred genes in microglia using AAV-derived vectors, as well as the first utilization of recombinant AAV-5 vectors in any macrophage lineage. These results provide strong encouragement for the application of these vectors and this approach for delivering therapeutic and other genes selectively to microglia.
authors.affiliation: Harvard Institutes of Medicine and Beth Israel Deaconess Medical Center, Boston, MA, USA.
authors.forename: M
authors.initials: M
authors.lastname: Cucchiarini
authors.forename: X L
authors.initials: XL
authors.lastname: Ren
authors.forename: G
authors.initials: G
authors.lastname: Perides
authors.forename: E F
authors.initials: EF
authors.lastname: Terwilliger
mesh_terms: D000818:Animals; D001921:Brain / Q000378:metabolism* / Q000473:pathology; D001927:Brain Diseases / Q000378:metabolism / Q000628:therapy*; D000229:Dependovirus / Q000145:classification / Q000235:genetics*; D015870:Gene Expression; D018390:Gene Targeting; D005818:Genetic Engineering; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors / Q000008:administration & dosage* / Q000235:genetics; D006801:Humans; D016676:Macrophages, Alveolar / Q000378:metabolism; D008297:Male; D017628:Microglia / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012703:Serotyping; D014161:Transduction, Genetic / Q000379:methods